Insider Trades62 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2026 | Sell | ENTA | Scott T. Rottinghaus | Chief Medical Officer | 1,467 | $13.34 | $377.5M | -24.43% | +83.83% | $19.6K | -5.81% | — | Buy Now |
| Feb 12, 2026 | Sell | ENTA | Matthew Paul Kowalsky | Chief Legal Officer | 1,902 | $14.25 | $377.5M | -24.43% | +83.83% | $27.1K | -34.63% | — | Buy Now |
| Feb 12, 2026 | Sell | ENTA | Tara Lynn Kieffer | Chief Product Strategy Officer | 3,257 | $14.25 | $377.5M | -24.43% | +83.83% | $46.4K | -8.76% | — | Buy Now |
| Feb 12, 2026 | Sell | ENTA | Brendan Luu | Chief Business Officer | 3,257 | $14.25 | $377.5M | -24.43% | +83.83% | $46.4K | -7.26% | — | Buy Now |
| Feb 12, 2026 | Sell | ENTA | Yat Sun Or | Chief Scientific Officer | 3,413 | $14.25 | $377.5M | -24.43% | +83.83% | $48.6K | -0.90% | — | Buy Now |
| Feb 12, 2026 | Sell | ENTA | Scott T. Rottinghaus | Chief Medical Officer | 3,413 | $14.25 | $377.5M | -24.43% | +83.83% | $48.6K | -11.91% | — | Buy Now |
| Feb 12, 2026 | Sell | ENTA | Jay R. Luly | President and CEO | 6,155 | $14.25 | $377.5M | -24.43% | +83.83% | $87.7K | -0.70% | — | Buy Now |
| Dec 5, 2025 | Sell | ENTA | Kathleen S. Capps | — | 323 | $14.23 | $377.5M | -24.43% | +83.83% | $4.6K | -3.71% | — | Buy Now |
| Dec 5, 2025 | Sell | ENTA | Harry R. Iii Trout | — | 542 | $14.23 | $377.5M | -24.43% | +83.83% | $7.7K | -3.21% | — | Buy Now |
| Dec 5, 2025 | Sell | ENTA | Scott T. Rottinghaus | Chief Medical Officer | 798 | $14.23 | $377.5M | -24.43% | +83.83% | $11.4K | -3.53% | — | Buy Now |
| Dec 5, 2025 | Sell | ENTA | Brendan Luu | Chief Business Officer | 1,394 | $14.23 | $377.5M | -24.43% | +83.83% | $19.8K | -3.51% | — | Buy Now |
| Dec 5, 2025 | Sell | ENTA | Tara Lynn Kieffer | Chief Product Strategy Officer | 2,106 | $14.23 | $377.5M | -24.43% | +83.83% | $30.0K | -6.44% | — | Buy Now |
| Dec 5, 2025 | Sell | ENTA | Yat Sun Or | Chief Scientific Officer | 2,390 | $14.23 | $377.5M | -24.43% | +83.83% | $34.0K | -0.64% | — | Buy Now |
| Dec 5, 2025 | Sell | ENTA | Jay R. Luly | President and CEO | 4,743 | $14.23 | $377.5M | -24.43% | +83.83% | $67.5K | -0.55% | — | Buy Now |
| Dec 1, 2025 | Sell | ENTA | Kathleen S. Capps | — | 292 | $14.01 | $377.5M | -24.43% | +83.83% | $4.1K | -1.63% | — | Buy Now |
| Dec 1, 2025 | Sell | ENTA | Harry R. Iii Trout | — | 485 | $13.99 | $377.5M | -24.43% | +83.83% | $6.8K | -1.40% | — | Buy Now |
| Dec 1, 2025 | Sell | ENTA | Brendan Luu | Chief Business Officer | 498 | $14.12 | $377.5M | -24.43% | +83.83% | $7.0K | -1.24% | — | Buy Now |
| Dec 1, 2025 | Sell | ENTA | Yat Sun Or | Chief Scientific Officer | 753 | $14.12 | $377.5M | -24.43% | +83.83% | $10.6K | -0.20% | — | Buy Now |
| Dec 1, 2025 | Sell | ENTA | Tara Lynn Kieffer | Chief Product Strategy Officer | 753 | $14.12 | $377.5M | -24.43% | +83.83% | $10.6K | -2.25% | — | Buy Now |
| Dec 1, 2025 | Sell | ENTA | Jay R. Luly | President and CEO | 1,885 | $14.12 | $377.5M | -24.43% | +83.83% | $26.6K | -0.22% | — | Buy Now |
| Aug 8, 2025 | Sell | ENTA | Scott T. Rottinghaus | Chief Medical Officer | 2,217 | $6.99 | $377.5M | -24.43% | +83.83% | $15.5K | -8.94% | — | Buy Now |
| Feb 12, 2025 | Sell | ENTA | Scott T. Rottinghaus | Chief Medical Officer | 2,861 | $5.59 | $377.5M | -24.43% | +83.83% | $16.0K | -10.34% | — | Buy Now |
| Feb 12, 2025 | Sell | ENTA | Paul J Mellett | Chief Fin. & Admin Officer | 3,326 | $5.59 | $377.5M | -24.43% | +83.83% | $18.6K | -3.35% | — | Buy Now |
| Feb 12, 2025 | Sell | ENTA | Tara Lynn Kieffer | Chief Product Strategy Officer | 3,326 | $5.59 | $377.5M | -24.43% | +83.83% | $18.6K | -9.04% | — | Buy Now |
| Feb 12, 2025 | Sell | ENTA | Brendan Luu | Chief Business Officer | 3,326 | $5.59 | $377.5M | -24.43% | +83.83% | $18.6K | -7.64% | — | Buy Now |
| Feb 12, 2025 | Sell | ENTA | Yat Sun Or | Chief Scientific Officer | 4,324 | $5.59 | $377.5M | -24.43% | +83.83% | $24.2K | -1.14% | — | Buy Now |
| Feb 12, 2025 | Sell | ENTA | Jay R. Luly | President and CEO | 7,484 | $5.59 | $377.5M | -24.43% | +83.83% | $41.8K | -0.86% | — | Buy Now |
| Feb 12, 2025 | Buy | ENTA | Jay R. Luly | President and CEO | 45,000 | $5.69 | $377.5M | -24.43% | +83.83% | $256.1K | +5.61% | — | Buy Now |
| Dec 6, 2024 | Sell | ENTA | Scott T. Rottinghaus | Chief Medical Officer | 866 | $8.06 | $377.5M | -24.43% | +83.83% | $7.0K | -4.61% | — | Buy Now |
| Dec 6, 2024 | Sell | ENTA | Brendan Luu | Chief Business Officer | 2,283 | $8.06 | $377.5M | -24.43% | +83.83% | $18.4K | -5.96% | — | Buy Now |
| Dec 6, 2024 | Sell | ENTA | Tara Lynn Kieffer | Chief Product Strategy Officer | 2,283 | $8.06 | $377.5M | -24.43% | +83.83% | $18.4K | -7.23% | — | Buy Now |
| Dec 6, 2024 | Sell | ENTA | Paul J Mellett | Chief Fin. & Admin Officer | 2,591 | $8.06 | $377.5M | -24.43% | +83.83% | $20.9K | -2.75% | — | Buy Now |
| Dec 6, 2024 | Sell | ENTA | Yat Sun Or | Chief Scientific Officer | 2,591 | $8.06 | $377.5M | -24.43% | +83.83% | $20.9K | -0.70% | — | Buy Now |
| Dec 6, 2024 | Sell | ENTA | Jay R. Luly | President and CEO | 5,142 | $8.06 | $377.5M | -24.43% | +83.83% | $41.4K | -0.64% | — | Buy Now |
| Dec 1, 2024 | Sell | ENTA | Tara Lynn Kieffer | Chief Product Strategy Officer | 753 | $8.60 | $377.5M | -24.43% | +83.83% | $6.5K | -2.33% | — | Buy Now |
| Dec 1, 2024 | Sell | ENTA | Brendan Luu | Chief Business Officer | 753 | $8.60 | $377.5M | -24.43% | +83.83% | $6.5K | -1.93% | — | Buy Now |
| Dec 1, 2024 | Sell | ENTA | Paul J Mellett | Chief Fin. & Admin Officer | 1,595 | $8.60 | $377.5M | -24.43% | +83.83% | $13.7K | -1.66% | — | Buy Now |
| Dec 1, 2024 | Sell | ENTA | Yat Sun Or | Chief Scientific Officer | 1,595 | $8.60 | $377.5M | -24.43% | +83.83% | $13.7K | -0.43% | — | Buy Now |
| Dec 1, 2024 | Sell | ENTA | Jay R. Luly | President and CEO | 3,829 | $8.60 | $377.5M | -24.43% | +83.83% | $32.9K | -0.47% | — | Buy Now |
| Jul 11, 2024 | Sell | ENTA | Scott T. Rottinghaus | Chief Medical Officer | 17,320 | $13.80 | $377.5M | -24.43% | +83.83% | $239.1K | -3.62% | 10b5-1 | Buy Now |
| Jun 17, 2024 | Sell | ENTA | Tara Lynn Kieffer | Chief Product Strategy Officer | 7,266 | $12.33 | $377.5M | -24.43% | +83.83% | $89.6K | -18.35% | 10b5-1 | Buy Now |
| Feb 26, 2024 | Buy | ENTA | Nathaniel S. Gardiner | Chief Legal Officer | 5,187 | $8.99 | $377.5M | -24.43% | +83.83% | $46.6K | +3.50% | — | Buy Now |
| Feb 12, 2024 | Sell | ENTA | Scott T. Rottinghaus | Chief Medical Officer | 755 | $12.41 | $377.5M | -24.43% | +83.83% | $9.4K | -2.60% | — | Buy Now |
| Feb 12, 2024 | Sell | ENTA | Paul J Mellett | Chief Fin. & Admin Officer | 973 | $12.41 | $377.5M | -24.43% | +83.83% | $12.1K | -1.00% | — | Buy Now |
| Feb 12, 2024 | Sell | ENTA | Nathaniel S. Gardiner | Chief Legal Officer | 973 | $12.41 | $377.5M | -24.43% | +83.83% | $12.1K | -1.36% | — | Buy Now |
| Feb 12, 2024 | Sell | ENTA | Tara Lynn Kieffer | Chief Product Strategy Officer | 973 | $12.41 | $377.5M | -24.43% | +83.83% | $12.1K | -2.40% | — | Buy Now |
| Feb 12, 2024 | Sell | ENTA | Brendan Luu | Chief Business Officer | 973 | $12.41 | $377.5M | -24.43% | +83.83% | $12.1K | -2.43% | — | Buy Now |
| Feb 12, 2024 | Sell | ENTA | Yat Sun Or | Chief Scientific Officer | 1,080 | $12.41 | $377.5M | -24.43% | +83.83% | $13.4K | -0.29% | — | Buy Now |
| Feb 12, 2024 | Sell | ENTA | Jay R. Luly | President and CEO | 1,584 | $12.41 | $377.5M | -24.43% | +83.83% | $19.7K | -0.20% | — | Buy Now |
| Dec 5, 2023 | Sell | ENTA | Scott T. Rottinghaus | Sr. VP & CMO | 534 | $9.63 | $377.5M | -24.43% | +83.83% | $5.1K | -1.98% | — | Buy Now |
| Dec 5, 2023 | Sell | ENTA | Tara Lynn Kieffer | Sr. VP, New Prod. Strat. & Dev | 2,125 | $9.63 | $377.5M | -24.43% | +83.83% | $20.5K | -5.40% | — | Buy Now |
| Dec 5, 2023 | Sell | ENTA | Brendan Luu | Sr. VP, Business Dev. | 2,125 | $9.63 | $377.5M | -24.43% | +83.83% | $20.5K | -5.47% | — | Buy Now |
| Dec 5, 2023 | Sell | ENTA | Paul J Mellett | Sr. VP, Finance & Admin. & CFO | 2,412 | $9.63 | $377.5M | -24.43% | +83.83% | $23.2K | -2.51% | — | Buy Now |
| Dec 5, 2023 | Sell | ENTA | Yat Sun Or | Sr. VP, R&D & CSO | 2,412 | $9.63 | $377.5M | -24.43% | +83.83% | $23.2K | -0.65% | — | Buy Now |
| Dec 5, 2023 | Sell | ENTA | Nathaniel S. Gardiner | Sr. VP & General Counsel | 2,412 | $9.63 | $377.5M | -24.43% | +83.83% | $23.2K | -3.42% | — | Buy Now |
| Dec 5, 2023 | Sell | ENTA | Jay R. Luly | President and CEO | 7,230 | $9.63 | $377.5M | -24.43% | +83.83% | $69.6K | -0.89% | — | Buy Now |
| Dec 1, 2023 | Sell | ENTA | Tara Lynn Kieffer | Sr. VP, New Prod. Strat. & Dev | 753 | $9.49 | $377.5M | -24.43% | +83.83% | $7.1K | -1.88% | — | Buy Now |
| Dec 1, 2023 | Sell | ENTA | Brendan Luu | Sr. VP, Business Dev. | 753 | $9.49 | $377.5M | -24.43% | +83.83% | $7.1K | -1.90% | — | Buy Now |
| Dec 1, 2023 | Sell | ENTA | Paul J Mellett | Sr. VP, Finance & Admin. & CFO | 1,595 | $9.49 | $377.5M | -24.43% | +83.83% | $15.1K | -1.63% | — | Buy Now |
| Dec 1, 2023 | Sell | ENTA | Yat Sun Or | Sr. VP, R&D & CSO | 1,595 | $9.49 | $377.5M | -24.43% | +83.83% | $15.1K | -0.43% | — | Buy Now |
| Dec 1, 2023 | Sell | ENTA | Nathaniel S. Gardiner | Sr. VP & General Counsel | 1,595 | $9.49 | $377.5M | -24.43% | +83.83% | $15.1K | -2.21% | — | Buy Now |
| Dec 1, 2023 | Sell | ENTA | Jay R. Luly | President and CEO | 5,787 | $9.49 | $377.5M | -24.43% | +83.83% | $54.9K | -0.71% | — | Buy Now |